Epithalon
Tetrapeptide studied in Russian gerontology for telomerase activation and pineal regulation. Human data limited to small studies.
At a glance
- Common vial size
- 50 mg
- Reference dose
- 10 mg
- Frequency
- Daily × 10–20 days, cycled
Reference titration protocol
10 mg/day × 10–20 days, cycled.
| Step | Dose | Duration | Administrations / week |
|---|---|---|---|
| 1 | 10 mg | 2 weeks | 7× |
A 50 mg vial reconstituted with 5 mL of bacteriostatic water yields 10 mg/mL. Confirm the diluent and volume against the labeling that ships with the vial.
Open this configuration in the calculatorAvailable formulations
Presentations carried across the VitaRelay pharmacy network, including 503A compounded, 503B outsourcing facility, and research & development sourcing. Pricing and state-level availability are shown to verified accounts only.
- Capsule/Tablet503A
- Injectable503A
- Lyophilized PowderRUO
References
Often used with
Compounds commonly discussed alongside Epithalon in published protocols and prescriber requests. Listed for reference only — not a clinical recommendation, and not a suggestion to co-administer.
Pricing and ordering are for verified accounts
VitaRelay serves licensed practices, prescribers, and pharmacies. Catalog pricing, availability by state, and ordering are available after your account is verified.
